483
Fitbit LLCFDA 483 - Fitbit LLC - May 22, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Fitbit LLC in San Francisco, CA, revealed significant deficiencies in a non-significant risk device study. The firm failed to maintain IRB approval, keep accurate and complete records of adverse device effects, and ensure investigator compliance. These issues indicate serious non-compliance with regulations for investigational device exemptions.
Open in Dashboard
ID · ae108e2a-3f4a-4c43-8d56-a216d6988d2e